By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Life Care NewsLife Care NewsLife Care News
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
Search
Technology
  • Advertise
  • Advertise
Health
Entertainment
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved.
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Reading: IHS Passes Rigorous Audit for World-Wide Distribution of its Insignis Infusion System
Share
Notification Show More
Font ResizerAa
Life Care NewsLife Care News
Font ResizerAa
  • Education
  • Automobile
  • Entertainment
  • News
  • Tech
  • Sports
Search
  • Home
  • Home
    • Home 1
    • Default Home 5
  • Categories
  • Categories
    • Tech
    • Entertainment
    • Automobile
    • Sports
    • Education
    • News
    • Health
  • Bookmarks
  • Bookmarks
  • More Foxiz
    • Sitemap
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
News

IHS Passes Rigorous Audit for World-Wide Distribution of its Insignis Infusion System

PRNW Agency
Last updated: 16/01/2025 7:52 AM
PRNW Agency
Share
4 Min Read
IHS Passes Rigorous Audit for World-Wide Distribution of its Insignis Infusion System
SHARE
IHS Passes Rigorous Audit for World-Wide Distribution of its Insignis Infusion System

Innovative Health Sciences has successfully secured the exclusive Medical Device Regulations Quality Management System Certificate from BSI (CE MDR QMS), a leading notified body, thus facilitating the introduction of the Insignis™ Infusion System into the world market.

CHESTER, N.Y., Jan. 15, 2025 /PRNewswire/ — Innovative Health Sciences (IHS) proudly announces a remarkable milestone in its journey to introduce the Insignis™ Infusion System into the global market. The Company successfully passed the challenging final stage of the two-stage audit for the European Medical Device Regulation (MDR) Quality Management System (QMS) conducted by BSI. The Insignis System addresses a critical unmet need in the infusion market for an affordable, portable mechanical syringe infusion device that accurately and safely delivers medications both intravenously and subcutaneously. Together with our FDA premarket clearance received on March 1, 2024, our technologically disruptive and lower-cost Insignis Infusion System is now poised to become a new standard for routine infusions worldwide. 

Achieving MDR compliance at such an early stage highlights the dedication and expertise of the IHS team. This rigorous process required a meticulous adherence to MDR standards across all aspects of the device lifecycle, including conception, design, manufacturing, and post-market surveillance.

The importance of meeting the requirements for MDR certification for our Company cannot be overstated. Existing marketing clearances in the EU under CE Mark are expiring shortly and the arduous MDR certification is accepted not only in the EU, but in several countries throughout the world. 

- Advertisement -

A Collaborative Team Effort
The success of this audit is a testament to the extraordinary achievements of the IHS team. Leading the charge were Regulatory Affairs Director, Sheppard Bently and Lead Quality Engineer, Tejasree Yenigalla. Their work was supported by Senior Mechanical Engineer, Riad Gani, known for his multifaceted skills; Senior Quality Technician, Cristina Berkeley; Marketing Director, Tyler Kinner; and Document Control Specialist, Tim Tate – all of whom contributed tremendous extra effort towards our seamless collaboration with the auditing group.

“This accomplishment propels our company into global markets with a groundbreaking and highly versatile system that will make life-saving medications more accessible,” said Andy Sealfon, CEO of IHS. “Given the increasing demand for reliable and affordable infusion systems– driven by natural disasters, military needs, aging populations, and the growing prevalence of chronic diseases—the Insignis System is uniquely positioned to save and improve many lives.”

About the Insignis Infusion System
The Insignis Syringe Infusion System is a robust, non-electric device designed for routine subcutaneous and intravenous medication delivery. Portable, lightweight, accurate, and easy to use, it is ideal to operate for a wide range of medications and environments.

With 40 years of expertise in subcutaneous medication delivery, our design team has developed capabilities for infusing large volumes with shorter infusion times, reducing pain and discomfort for patients. The Insignis System is particularly effective for patients requiring subcutaneous immunoglobulin (SCIg) for Primary or Secondary Immune Deficiency and neuromodulation therapies. These additional subcutaneous therapies include deferoxamine, factor, anti-nausea drugs, and monoclonal antibodies.  

Looking ahead, IHS is exploring breakthrough applications for subcutaneous delivery of antibiotics (e.g., ceftriaxone, ampicillin, gentamicin), hydration, apomorphine, anti-infectives, and cardiac support medications. These innovations aim to expand patient access to simpler and more effective infusion solutions.

- Advertisement -

The future is bright for the Insignis Infusion System, as it stands ready to transform the infusion landscape and reach millions of unserved patients and improve outcomes worldwide.

Logo – https://mma.prnewswire.com/media/2475495/IHS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/ihs-passes-rigorous-audit-for-world-wide-distribution-of-its-insignis-infusion-system-302351929.html

- Advertisement -

You Might Also Like

Nescaf Fusion enables food service providers to deliver personalized coffee experiences

Let There Be Light: Vivid Sydney 2025 Kicks Off

Memorial Day Weekend in Las Vegas Will Feature Extravagant Pool Parties, Unforgettable Entertainment and Sensational Special Events

LEO Pharma Presents New Late-Breaking Delgocitinib Cream Data For the Third Consecutive Year at AAD 2025

MBZUAI welcomes the world to Abu Dhabi for a leading NLP conference

TAGGED:auditbsicertificatechester nydevicedistributionexclusivefacilitatingHealthihsinfusioninnovativeinsignisintroductionjanleadingmanagementmarketmdrmedicalnotifiedpassesqmsqualityregulationsrigoroussciencessecuredstagesuccessfullysystemthusuncategorizedworldworld-wide

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article Masdar’s Capacity Up By 150% to Over 50GW In Two Years Cementing Place as Global Clean Energy Leader Masdar’s Capacity Up By 150% to Over 50GW In Two Years Cementing Place as Global Clean Energy Leader
Next Article Shaping the Future of Learning: ViewSonic to Showcase AI and Innovative Solutions at Bett 2025 Shaping the Future of Learning: ViewSonic to Showcase AI and Innovative Solutions at Bett 2025

Stay Connected

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
Google NewsFollow
LinkedInFollow
MediumFollow
- Advertisement -

Latest News

ARKS forays into the world of fragrances with the launch of its debut scent ‘ARKS Day’
ARKS forays into the world of fragrances with the launch of its debut scent ‘ARKS Day’
Travel 09/06/2025
Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of its FIH Study
Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of its FIH Study
Health 09/06/2025
ELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. Is Fair to Shareholders
ELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. Is Fair to Shareholders
Business 09/06/2025
KBRA Releases Research  Private Credit: Business Development Company (BDC) Ratings Compendium: First-Quarter 2025
KBRA Releases Research Private Credit: Business Development Company (BDC) Ratings Compendium: First-Quarter 2025
Business 09/06/2025
//

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Quick Link

  • About Us
  • Contact Us
  • Editorial Guidelines
  • Privacy Policy
  • Terms and Conditions

Top Categories

  • Automobile
  • Education
  • Entertainment
  • Health
  • News
  • Sports
  • Tech

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Life Care NewsLife Care News
Follow US
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?